drugset / Trial / NCT03629067

Combination of Fimasartan/Amlodipine/Hydrochlorothiazide in Healthy Male Subjects

NCT03629067

Phase 1 Completed 60 enrolled Boryung Pharmaceutical Co., Ltd
RandomizedCrossoverOpen-labelTreatment

Summary

The purpose of this study is to evaluate the Pharmacokinetics and safety/tolerability between Fimasartan/Amlodipine/Hydrochlorothiazide and co administration of Fimasartan/Amlodipine and Hydrochlorothiazide in Healthy volunteers.

Timeline

Start
2018-09-13
Primary completion
2018-11-29
Completion
2018-12-27

Drugs

EvaluationDrugModalityDoseRoute
Subject Amlodipine Other / unclassified
Subject Fimasartan Small molecule
Subject Hydrochlorothiazide Unknown

Indications

No indication recorded.